June 10, 2022 Acad, Gov/Utilities Roche announces positive data from broad blood cancer portfolio at European Hematology Association Annual Meeting Read more
June 9, 2022 Acad, Gov/Utilities Clinical Research/Diagn. U.S. FDA approves Foundation Medicine’s FoundationOne®CDx as a companion diagnostic for Roche’s Rozlytrek® (entrectinib) Read more
June 9, 2022 Uncategorized European Commission approves Roche’s Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer Read more
June 8, 2022 Uncategorized European Commission approves Roche’s first-in-class bispecific antibody Lunsumio for people with relapsed or refractory follicular lymphoma Read more
May 31, 2022 Acad, Gov/Utilities FDA approves Roche’s Evrysdi for use in babies under two months with spinal muscular atrophy (SMA) Read more
May 27, 2022 Clinical Research/Diagn. Product Launch New pivotal data demonstrate clinical benefit of Roche’s glofitamab, a potential first-in-class bispecific antibody for people with aggressive lymphoma Read more
May 27, 2022 Clinical Research/Diagn. Product Launch New pivotal data demonstrate clinical benefit of Roche’s glofitamab, a potential first-in-class bispecific antibody for people with aggressive lymphoma Read more
May 25, 2022 Uncategorized Roche’s Polivy combination approved by European Commission for people with previously untreated diffuse large B-cell lymphoma Read more
May 25, 2022 Life Science Tools Roche develops unique PCR tests to detect the monkeypox virus Read more
May 25, 2022 Life Science Tools Roche develops unique PCR tests to detect the monkeypox virus Read more
